These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 10596737
1. Anabolic androgenic steroids and suicide. Thiblin I, Runeson B, Rajs J. Ann Clin Psychiatry; 1999 Dec; 11(4):223-31. PubMed ID: 10596737 [Abstract] [Full Text] [Related]
4. Cause and manner of death among users of anabolic androgenic steroids. Thiblin I, Lindquist O, Rajs J. J Forensic Sci; 2000 Jan; 45(1):16-23. PubMed ID: 10641914 [Abstract] [Full Text] [Related]
8. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men. Sharma A, Grant B, Islam H, Kapoor A, Pradeep A, Jayasena CN. Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138 [Abstract] [Full Text] [Related]
9. Effective treatment and prevention of attempted suicide, anxiety, and aggressiveness with fluoxetine, despite proven use of androgenic anabolic steroids. Amaral JMX, Padilha MC, Chagas SV, Baker JS, Mullen C, Vieira Neto L, Aquino Neto FR, Cruz MS. Drug Test Anal; 2021 Jan; 13(1):197-202. PubMed ID: 32808487 [Abstract] [Full Text] [Related]
11. The Central Effects of Androgenic-anabolic Steroid Use. Mędraś M, Brona A, Jóźków P. J Addict Med; 2018 Jan; 12(3):184-192. PubMed ID: 29470183 [Abstract] [Full Text] [Related]
12. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG. Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171 [Abstract] [Full Text] [Related]
13. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study. Grant B, Campbell J, Pradeep A, Burns AD, Bassett P, Abbara A, Saket P, Minhas S, Dhillo WS, McVeigh J, Bhasin S, Jayasena CN. Eur J Endocrinol; 2023 Dec 06; 189(6):601-610. PubMed ID: 38102386 [Abstract] [Full Text] [Related]
14. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Gruber AJ, Pope HG. Psychother Psychosom; 2000 Dec 06; 69(1):19-26. PubMed ID: 10601831 [Abstract] [Full Text] [Related]
15. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? Kanayama G, Cohane GH, Weiss RD, Pope HG. J Clin Psychiatry; 2003 Feb 06; 64(2):156-60. PubMed ID: 12633124 [Abstract] [Full Text] [Related]
16. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity]. Lykhonosov MP, Babenko AY, Makarin VA, Fedotov YN. Probl Endokrinol (Mosk); 2019 Nov 23; 65(5):341-350. PubMed ID: 32202738 [Abstract] [Full Text] [Related]
17. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users. Griffiths S, Jacka B, Degenhardt L, Murray SB, Larance B. Drug Alcohol Rev; 2018 Jul 23; 37(5):664-670. PubMed ID: 29484740 [Abstract] [Full Text] [Related]
18. Anabolic-androgenic steroids and the risk of imprisonment. Christoffersen T, Andersen JT, Dalhoff KP, Horwitz H. Drug Alcohol Depend; 2019 Oct 01; 203():92-97. PubMed ID: 31421475 [Abstract] [Full Text] [Related]
19. Anabolic androgenic steroids and aggression: studies using animal models. McGinnis MY. Ann N Y Acad Sci; 2004 Dec 01; 1036():399-415. PubMed ID: 15817752 [Abstract] [Full Text] [Related]
20. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Kanayama G, Pope HG, Cohane G, Hudson JI. Drug Alcohol Depend; 2003 Jul 20; 71(1):77-86. PubMed ID: 12821208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]